Screener
Keros Therapeutics KROS Q1 2025 earnings
Reported May 6, 2025 · Before market open
Revenue$211.2MBeat by $154.6M
EPS$3.62Beat by $3.63
Revenue estimate$56.6M
EPS estimate-$0.01
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$14.8M
EPS estimate-$0.96
Versus estimates
Revenue
Q1 2026$367.0KMiss by $1.6MQ4 2025$385.0KMiss by $3.3MQ3 2025$14.3MBeat by $10.6MQ2 2025$18.2MBeat by $15.0M
Q1 2025$211.2MBeat by $154.6M
Diluted EPS
FAQ
- When did Keros Therapeutics report Q1 2025 earnings?
- Keros Therapeutics (KROS) reported Q1 2025 earnings on May 6, 2025 before market open.
- What were Keros Therapeutics's Q1 2025 revenue and EPS?
- Keros Therapeutics reported revenue of $211.2M and eps of $3.62 for Q1 2025.
- Did Keros Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $56.6M by $154.6M. EPS beat the consensus estimate of $-0.01 by $3.63.
- How did Keros Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 254413.3% from $83.0K a year earlier.
- Where can I find Keros Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001664710-25-000045) and the 10-Q periodic report (0001664710-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.
